NS
Nagavenkatahareeshkumar Solleti
About Nagavenkatahareeshkumar Solleti
Data last updated:
Nagavenkatahareeshkumar Solleti is a Director at Concord Drugs Limited (since 2021). The company operates in Pharma. Concord Drugs Limited reported revenue of ₹45.26 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 13 Feb 2021 | 1995 | ₹45.26 Cr (FY 2025) | Active |
Board colleagues of Nagavenkatahareeshkumar Solleti
| Name | DIN | Company | Designation |
|---|---|---|---|
| Koni Reddy Seelam | 02829319 | Concord Drugs Limited | Whole-Time Director |
| Koni Reddy Seelam | Concord Drugs Limited | Cfo | |
| Nagi Reddy Seelam | 01764665 | Concord Drugs Limited | Managing Director |
| Namratha | Concord Drugs Limited | Company Secretary | |
| Satyam Reddy Gopidi | 11282375 | Concord Drugs Limited | Director |
| Seelam Manojkumarreddy | 06991382 | Concord Drugs Limited | Whole-Time Director |
| Sumeela Kasu | 09571540 | Concord Drugs Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nagavenkatahareeshkumar Solleti
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nagavenkatahareeshkumar Solleti
Nagavenkatahareeshkumar Solleti currently holds 1 directorship: Concord Drugs Limited (Director, since 13 Feb 2021, revenue ₹45.26 Cr (FY 2025)).
Nagavenkatahareeshkumar Solleti was first appointed on 13 Feb 2021 as Director at Concord Drugs Limited.
The current boards of Nagavenkatahareeshkumar Solleti's companies include Koni Reddy Seelam (Concord Drugs Limited), Koni Reddy Seelam (Concord Drugs Limited), Nagi Reddy Seelam (Concord Drugs Limited), Namratha (Concord Drugs Limited), Satyam Reddy Gopidi (Concord Drugs Limited), Seelam Manojkumarreddy (Concord Drugs Limited), among others.